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Fluorescence Polarization Immunoassay and Enzyme Immunoassay Compared for Free Vaiproic Acid In Serum Ultrafiltrates from Epileptic Patients

To the Editor:
Valproic acid (VPA; Depakene#{174}; Depakote#{174}) is indicated for use both as the sole and adjunctive therapy in the treatment of simple (petit mal) and complex absence seizures. It may also be used adjunctively in patients with multiple seizure types, which includes absence seizures. Adjustment of VPA dosage in patients with convulsive disorders is routinely guided by measurements of total VPA concentration-i.e., both free and protein bound-in sorum. Control of seizures reportedly is optimum when total concentrations of VPA in serum are 50 to 100 mg/L. However, the pharmacological activity of VPA is related to the concentration of the free component which-even in the absence of pathological conditions such as uremia, hypoalbuminemia, or drugs that compete with VPA for binding sites on protein-is widely variable (1) .
Abbott Diagnostics (North Chicago, IL) is in the process of introducing an assay for free valproic acid for use with their automated fluorescence polarization immunoassay in the TDx Analyzer. They hope this can be used to quantify free VPA in ultrafiltrate of serum. To evaluate this TDx system, I used it to determine free VPA in serum from 47 patients and compared these results with values obtained by enzyme immunoassay (EMrr; Syva Co., Palo Alto, CA 94303). I also used the TDx to determine total serum VPA, compared the results with the results for free VPA concentrations, and calculated the variability of protein binding of VPA.
I used samples from 47 patients (20 women, 27 men, mean age 25.6 years) selected for the study without conscious bias. All 47 patients had longfalling epilepsy, for which they were being treated as outpatients at the Epilepsy Center of Michigan. All patients were receiving VPA medication; 31 patients were also receiving phenytoin, 19 phenobarbital, 13 carbamazepine, four ethosuximide, and two primidone. As Table i shows, the observed variability of percent of free VPA for the 47 patients investigated is rather large (range 7.98 to i9.53%). Clearly, such wide fluctuations preclude an assumption of some constant fraction of free VPA when only total VPA concentration is measured. Use of alternative methodologies-especially those as convenient, fast, and reliable as the TDx procedure-for free VPA (and correlation with clinical status of the patient) may eventually precisely define the "free VPA therapeutic window." 1.5-mL Microfuge tubes containing 1.0 mL of 150 mmol/L choline chloride solution layered onto 0.2 mL of dibutyl phthalate. After centrifugation for 2 mm at 8740 x g, the supernate and dibutyl phthalate layers were both removed by aspiration. With an Eppendorf pipette, 25 L of packed erythrocytes was then added to 2.5 mL of 15 mmol/L lithium solution. Sodium and potassium concentrations in the hemolysates were determined with a flame photometer (KLiNa Flame Photometer, Beckman).
For determination of free
The effect of dibutylphthalate on the volume of trapped plasma was determined; Table 1 shows the results. In this experiment, [3Hlinulin (Amersham, 5.6 kCi/mol) and nonradiolabeled inulin were added to heparinized blood to give a concentration of 15 j#{174}mollL (or 1.5 tCiJmL). One-tenthmilliliter volumes of blood were distributed into Microfuge tubes and centrifuged as described above (experiment C in Table 1 ). In some tubes, both dibutyl phthalate and choline chloride or only dibutyl phthalate were omitted (experiment A and B, respectively). Twenty-five-microliter samples of packed erythrocytes were transferred to other tubes containing 0.2 mL of 0.2 mol/L NaOH. After the cells were lysed, 0.25 mL of 100 g/L trichloroacetic acid solution was added and the tubes were centrifuged for 1 mm. Fourtenths milliliter of the supernate was then added to 4 mL of ACS-il (Amersham), and the radioactivity was counted in a liquid scintilation spectrophotometer.
In the complete system shown in experiment C in Table 1 , more than 99.7% of the plasma was removed from erythrocyte sediments by a single brief centrifligation. On the assumption that the plasma sodium concentration is 140 mmolIL and that in erythrocytes it is 9 mmolIL of cells, then 0.3% by volume of trapped plasma gives an approximately 4% higher value than the actual erythrocyte sodium concentration. The reduction of trapped plasma may be partly ascribed to a washout effect of diluted plasma by dibutyl phthalate, because erythrocytes passed through the oil layer during the centrifugation, and partly to a discrete separation of erythrocytes from the water layer by the oil.
In the next experiment, the effect of duration of centrifugation was determined. Within the range of 1 to 5 mm, no significant change in erythrocyte electrolyte concentration was observed. A slight reduction in electrolyte concentration, however, was observed if the tubes were allowed to stand for more than 5 mm after dilution of blood in a choline chloride solution. Thus the centrifugation must be done within 5 miii after dilution of the blood. After separation of the erythrocytes from the diluting medium by centrifugation, no such decrease was observed, even if the tubes were allowed to stand for 60 mm or longer. The effect of centrifugal force was not investigated, because this was fixed at 8740 x g. Pipetting a highly viscous erythrocyte sediment might produce a large volumetric error in determination of electrolyte concentration. This is not the case, however, because the CV as calculated from values obtained from 10 determinations on the same blood in a single assay was 2.5%. To minimize one possible source of error, we usually wipe erythrocytes off of the outer surface of pipette tips with soft paper and rinse the tips several times with hemolyzing solution.
The mean (n = 24) normal values for erythrocyte sodium and potassium concentration as determined by this method were 8.6 (SD 1.3) and 93.1 (SD 5.6) mmol/L of erythrocytes, respectively. We examined the relationship between erythrocyte sodium concentration, mmolIL of cells (x), and the maximal ouabain binding capacity as determined by the method of DeLuise et al.
(2) (y) in erythrocytes obtained from normal subjects and patients with obesity, hyperthyroidism, or essential hypertension. A significant correlation was observed between those variables (r = -0.573, p <0.001, a = 79). Since the maximal ouabain binding capacity has repeatedly been shown to correlate with the activity of (Na, K)-ATPase (sodium pump) of the cell (3, 4), these data imply that the present method gives a reasonable value for erythrocyte electrolyte concentration.
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have given the actual weight of material used to prepare their stock standard, which, although unambiguous, is unfortunately wrong and serves to underline the care required when converting molar units into mass units for the purpose of preparing solutions.
